DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)
- Previous Close
20.73 - Open
20.68 - Bid 21.20 x --
- Ask 21.21 x --
- Day's Range
20.59 - 21.25 - 52 Week Range
19.83 - 30.22 - Volume
7,724,824 - Avg. Volume
8,304,612 - Market Cap (intraday)
24.144B - Beta (5Y Monthly) 0.09
- PE Ratio (TTM)
18.76 - EPS (TTM)
1.13 - Earnings Date --
- Forward Dividend & Yield 0.60 (2.83%)
- Ex-Dividend Date Jun 9, 2023
- 1y Target Est
33.79
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. It provides Chinese and western patent medicines, ginseng tonic medicinal materials and Chinese herbal pieces, health care products, medical equipment, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.
www.dslyy.comRelated News
Performance Overview: 603233.SS
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603233.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603233.SS
Valuation Measures
Market Cap
24.14B
Enterprise Value
26.00B
Trailing P/E
18.79
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.00
Price/Book (mrq)
3.53
Enterprise Value/Revenue
1.08
Enterprise Value/EBITDA
14.21
Financial Highlights
Profitability and Income Statement
Profit Margin
5.33%
Return on Assets (ttm)
6.06%
Return on Equity (ttm)
18.97%
Revenue (ttm)
24.15B
Net Income Avi to Common (ttm)
1.29B
Diluted EPS (ttm)
1.13
Balance Sheet and Cash Flow
Total Cash (mrq)
3.74B
Total Debt/Equity (mrq)
71.08%
Levered Free Cash Flow (ttm)
1.25B
Research Analysis: 603233.SS
Company Insights: 603233.SS
603233.SS does not have Company Insights